Both 1,25(OH)2D3 and cediranib resulted in an increase in mRNA level for VEGFR3 (p < 0.05, Figure 8C), with an increasing trend in melanoma cells pretreated with vitamin D subsequently exposed to cediranib, yet without statistical significance in the latter. The gene discussed is FLT4; the disease is melanoma.